Stock Analiz

AMGN vs GILD stock comparison

Amgen vs. Gilead Sciences · data as of November 13, 2026

Amgen (AMGN) has a market value of about $251.9B, Gilead Sciences (GILD) about $208.5B. Over their latest twelve months Amgen had revenue of $38.9B and Gilead Sciences $31.0B.

On our five checks Gilead Sciences scores higher: 2.8 out of 5 (average) against 2.4 (weak).

By area, the stronger company is Gilead Sciences on value; Amgen on future growth; Gilead Sciences on track record; Gilead Sciences on financial health.

Amgen leads on 11 of the compared lines and Gilead Sciences on 11.

Side by side

AMGNGILD
Size and price
Market cap$251.9B$208.5B
Share price$465.67$168.08
Score
Overall score (of 5)2.42.8
Value01
Future growth32
Track record34
Financial health23
Shareholder returns44
Valuation
P/E (TTM)27.0—
Forward P/E19.520.3
Price / free cash flow26.315.1
Price / sales6.56.7
EV / EBITDA17.1559.5
PEG9.18—
DCF value vs. price−26%−35%
Business
Revenue$38.9B$31.0B
Net income$9.4B-$3.9B
Free cash flow$9.6B$13.8B
Net margin24.1%-12.5%
Gross margin (5-yr avg.)69.9%77.6%
ROIC (5-yr avg.)13.5%12.2%
Growth
Revenue growth (1 yr)10.0%2.4%
Revenue growth (5 yrs, per year)7.6%3.6%
EPS growth (5 yrs, per year)2.9%132.4%
Balance sheet and payouts
Net cash (cash minus debt)-$40.8B-$19.8B
Dividend yield2.16%1.95%
Shareholder yield2.2%2.9%
Analysts
Upside to average target−7%+4%
Consensus ratingHoldBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: AMGN TTM to September 30, 2026, GILD TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Amgen or Gilead Sciences?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Gilead Sciences scores 2.8 out of 5 and Amgen 2.4; the table shows where each one is stronger.

Which grows faster, Amgen or Gilead Sciences?

Over five years Amgen grew revenue about 7.6% a year and Gilead Sciences about 3.6% a year.

Which pays a higher dividend?

Amgen yields 2.16% and Gilead Sciences 1.95%.

Full Amgen analysis → Full Gilead Sciences analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.